Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polymerase II subunit J (RPB11) is part of the core enzyme responsible for transcribing messenger RNA and many small nuclear RNAs in eukaryotes[3]. As a protein component of the 12-subunit RNA polymerase II complex, it interacts with other subunits (notably RPB3 and RPB12) to stabilize the active center and maintain contact between DNA and the nascent RNA strand during transcription[2][3]. The polymerase orchestrates gene expression, responding to developmental and environmental cues by integrating signals through multiple regulatory protein complexes and transcription factors[1][5]. Mutations or inhibition of RNA polymerase II or its subunits disrupt normal transcription, leading to cell death or altered gene expression, which is relevant for cancer therapy and infectious disease drug development[1][4][3].
Inhibition of Pol II enzymatic activity to block mRNA synthesis (e.g., by preventing nucleotide addition or elongation)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase II subunit RPB11 (RPB11 (or POLR2J)).